Lehrstuhl für Klinische und Molekulare Virologie


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts (2022) Reuter N, Kropff B, Britt WJ, Mach M, Thomas M Journal article Bornavirus encephalitis as a differential diagnosis to seronegative autoimmune encephalitis (2022) Meier H, Bauer C, Finkenzeller W, Nentwich J, Staedt M, Steininger P, Korn K, et al. Journal article Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern (2022) Wratil PR, Stern M, Priller A, Willmann A, Almanzar G, Vogel E, Feuerherd M, et al. Journal article Covalent coupling of HIV-1 glycoprotein trimers to biodegradable calcium phosphate nanoparticles via genetically encoded aldehyde-tags (2022) Damm D, Kostka K, Weingärtner C, Wagner J, Rojas-Sánchez L, Gensberger-Reigl S, Sokolova V, et al. Journal article Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses (2022) Ray B, Ali I, Jana S, Mukherjee S, Pal S, Ray S, Schütz M, Marschall M Journal article Anti-SARS-CoV-2 Inhibitory Profile of New Quinoline Compounds in Cell Culture-Based Infection Models (2021) Herrmann L, Hahn F, Wangen C, Marschall M, Tsogoeva S Journal article Development of a PROTAC-based targeting strategy provides a mechanistically unique mode of anti-cytomegalovirus activity (2021) Hahn F, Hamilton ST, Wangen C, Wild M, Kicuntod J, Brückner N, Follett JE, et al. Journal article Iota-carrageenan inhibits replication of sars-cov-2 and the respective variants of concern alpha, beta, gamma and delta (2021) Fröba M, Große M, Setz C, Rauch P, Auth J, Spanaus L, Münch J, et al. Journal article Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization (2021) Lapuente D, Fuchs J, Willar J, Vieira Antao AI, Eberlein V, Uhlig N, Issmail L, et al. Journal article Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections (2021) Bénard A, Jacobsen A, Brunner M, Krautz C, Klösch B, Swierzy I, Naschberger E, et al. Journal article